Human diseases caused by germline and somatic abnormalities in microRNA and microRNA-related genes

Congenital Anomalies

Volumn 54, Issue 1, 2014, Pages 12-21

  Kawahara, Yukio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Chromosomal abnormality; Dicer TRBP complex; Drosha DGCR8 complex; Haploinsufficiency; Seed sequence

Indexed keywords

CHROMOSOMAL ABNORMALITY; DICER/TRBP COMPLEX; DROSHA/DGCR8 COMPLEX; HAPLOINSUFFICIENCY; SEED SEQUENCE;

ANIMALS; CHROMOSOME ABERRATIONS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENETIC DISEASES, INBORN; GERM CELLS; HUMANS; MICRORNAS;

EID: 84894431229     PISSN: 09143505     EISSN: 17414520     Source Type: Journal    
DOI: 10.1111/cga.12043     Document Type: Review

References (84)

1. Abelson JF, Kwan KY, O'Roak BJ etal. 2005. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 310:317-320.
2. Allegra D, Bilan V, Garding A etal. 2013. Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia. Leukemia doi:10.1038/leu.2013.246.
3. Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74.
4. Boultwood J, Fidler C, Strickson AJ etal. 2002. Narrowing and genomic annotation of the commonly deleted region of the 5q- syndrome. Blood 99:4638-4641.
5. Brest P, Lapaquette P, Souidi M etal. 2011. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet 43:242-245.
6. Calin GA, Dumitru CD, Shimizu M etal. 2002. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99:15524-15529.
7. Calin GA, Ferracin M, Cimmino A etal. 2005. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 353:1793-1801.
8. Celli J, van Bokhoven H, Brunner HG. 2003. Feingold syndrome: clinical review and genetic mapping. Am J Med Genet A 122A:294-300.
9. Chassaing N, Siani V, Carles D etal. 2005. X-linked dominant chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia. Am J Med Genet A 136A:307-312.
10. Chi SW, Zang JB, Mele A, Darnell RB. 2009. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460:479-486.
11. Creemers EE, Tijsen AJ, Pinto YM. 2012. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 110:483-495.
12. de Pontual L, Yao E, Callier P etal. 2011. Germline deletion of the miR-17 approximately 92 cluster causes skeletal and growth defects in humans. Nat Genet 43:1026-1030.
13. Deng H, Le WD, Xie WJ, Jankovic J. 2006. Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol Scand 114:400-402.
14. Dohner H, Stilgenbauer S, Benner A etal. 2000. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 343:1910-1916.
15. Dong JT, Boyd JC, Frierson HF Jr. 2001. Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer. Prostate 49:166-171.
16. Ebert BL, Pretz J, Bosco J etal. 2008. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 451:335-339.
17. Edelmann L, Pandita RK, Morrow BE. 1999. Low-copy repeats mediate the common 3-Mb deletion in patients with velo-cardio-facial syndrome. Am J Hum Genet 64:1076-1086.
18. Elton TS, Sansom SE, Martin MM. 2010. Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins. RNA Biol 7:540-547.
19. Esteller M. 2011. Non-coding RNAs in human disease. Nat Rev Genet 12:861-874.
20. Fabbrini G, Pasquini M, Aurilia C etal. 2007. A large Italian family with Gilles de la Tourette syndrome: clinical study and analysis of the SLITRK1 gene. Mov Disord 22:2229-2234.
21. Fenelon K, Mukai J, Xu B etal. 2011. Deficiency of Dgcr8, a gene disrupted by the 22q11.2 microdeletion, results in altered short-term plasticity in the prefrontal cortex. Proc Natl Acad Sci U S A 108:4447-4452.
22. Fisher SA, Tremelling M, Anderson CA etal. 2008. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 40:710-712.
23. Giagounidis AA, Germing U, Aul C. 2006. Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies. Clin Cancer Res 12:5-10.
24. Glas J, Seiderer J, Bues S etal. 2013. IRGM variants and susceptibility to inflammatory bowel disease in the German population. PLoS One 8:e54338.
25. Heravi-Moussavi A, Anglesio MS, Cheng SW etal. 2012. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med 366:234-242.
26. Hill DA, Ivanovich J, Priest JR etal. 2009. DICER1 mutations in familial pleuropulmonary blastoma. Science 325:965.
27. Hu Z, Chen J, Tian T etal. 2008. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118:2600-2608.
28. Hu Z, Liang J, Wang Z etal. 2009. Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30:79-84.
29. Hughes AE, Bradley DT, Campbell M etal. 2011. Mutation altering the miR-184 seed region causes familial keratoconus with cataract. Am J Hum Genet 89:628-633.
30. Iliff BW, Riazuddin SA, Gottsch JD. 2012. A single-base substitution in the seed region of miR-184 causes EDICT syndrome. Invest Ophthalmol Vis Sci 53:348-353.
31. Karali M, Peluso I, Gennarino VA etal. 2010. miRNeye: a microRNA expression atlas of the mouse eye. BMC Genomics 11:715.
32. Kawahara Y, Mieda-Sato A. 2012. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A 109:3347-3352.
33. Keen-Kim D, Mathews CA, Reus VI etal. 2006. Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses. Hum Mol Genet 15:3324-3328.
34. Klein U, Lia M, Crespo M etal. 2010. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell 17:28-40.
35. Kobrynski LJ, Sullivan KE. 2007. Velocardiofacial syndrome, DiGeorge syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370:1443-1452.
36. Kuhn AR, Schlauch K, Lao R, Halayko AJ, Gerthoffer WT, Singer CA. 2010. MicroRNA expression in human airway smooth muscle cells: role of miR-25 in regulation of airway smooth muscle phenotype. Am J Respir Cell Mol Biol 42:506-513.
37. Kumar MS, Pester RE, Chen CY etal. 2009. Dicer1 functions as a haploinsufficient tumor suppressor. Genes Dev 23:2700-2704.
38. Kumar MS, Narla A, Nonami A etal. 2011. Coordinate loss of a microRNA and protein-coding gene cooperate in the pathogenesis of 5q- syndrome. Blood 118:4666-4673.
39. Lambertz I, Nittner D, Mestdagh P etal. 2010. Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo. Cell Death Differ 17:633-641.
40. Lechner J, Bae HA, Guduric-Fuchs J etal. 2013. Mutational analysis of MIR184 in sporadic keratoconus and myopia. Invest Ophthalmol Vis Sci 54:5266-5272.
41. Lewis MA, Quint E, Glazier AM etal. 2009. An ENU-induced mutation of miR-96 associated with progressive hearing loss in mice. Nat Genet 41:614-618.
42. Li H, Kloosterman W, Fekete DM. 2010. MicroRNA-183 family members regulate sensorineural fates in the inner ear. J Neurosci 30:3254-3263.
43. Lim LP, Lau NC, Garrett-Engele P etal. 2005. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433:769-773.
44. Liu Z, Li G, Wei S etal. 2010. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116:4753-4760.
45. Marcelis CL, Hol FA, Graham GE etal. 2008. Genotype-phenotype correlations in MYCN-related Feingold syndrome. Hum Mutat 29:1125-1132.
46. Matsumoto S, Sakata Y, Suna S etal. 2013. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res 113:322-326.
47. McCarroll SA, Huett A, Kuballa P etal. 2008. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet 40:1107-1112.
48. Melo SA, Moutinho C, Ropero S etal. 2010. A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell 18:303-315.
49. Melo SA, Ropero S, Moutinho C etal. 2009. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 41:365-370.
50. Mencia A, Modamio-Hoybjor S, Redshaw N etal. 2009. Mutations in the seed region of human miR-96 are responsible for nonsyndromic progressive hearing loss. Nat Genet 41:609-613.
51. Mian M, Scandurra M, Chigrinova E etal. 2012. Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletion. Ann Oncol 23:729-735.
52. Migliazza A, Bosch F, Komatsu H etal. 2001. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood 97:2098-2104.
53. Mitchell PS, Parkin RK, Kroh EM etal. 2008. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105:10513-10518.
54. Miyaki S, Nakasa T, Otsuki S etal. 2009. MicroRNA-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 60:2723-2730.
55. Prescott NJ, Dominy KM, Kubo M etal. 2010. Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease. Hum Mol Genet 19:1828-1839.
56. Raveche ES, Salerno E, Scaglione BJ etal. 2007. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 109:5079-5086.
57. Ryan DG, Oliveira-Fernandes M, Lavker RM. 2006. MicroRNAs of the mammalian eye display distinct and overlapping tissue specificity. Mol Vis 12:1175-1184.
58. Sabbaghian N, Hamel N, Srivastava A, Albrecht S, Priest JR, Foulkes WD. 2012. Germline DICER1 mutation and associated loss of heterozygosity in a pineoblastoma. J Med Genet 49:417-419.
59. Sanuki R, Onishi A, Koike C etal. 2011. miR-124a is required for hippocampal axogenesis and retinal cone survival through Lhx2 suppression. Nat Neurosci 14:1125-1134.
60. Schofield CM, Hsu R, Barker AJ, Gertz CC, Blelloch R, Ullian EM. 2011. Monoallelic deletion of the microRNA biogenesis gene Dgcr8 produces deficits in the development of excitatory synaptic transmission in the prefrontal cortex. Neural Dev 6:11.
61. Schratt GM, Tuebing F, Nigh EA etal. 2006. A brain-specific microRNA regulates dendritic spine development. Nature 439:283-289.
62. Sethupathy P, Collins FS. 2008. MicroRNA target site polymorphisms and human disease. Trends Genet 24:489-497.
63. Shibata M, Nakao H, Kiyonari H, Abe T, Aizawa S. 2011. MicroRNA-9 regulates neurogenesis in mouse telencephalon by targeting multiple transcription factors. J Neurosci 31:3407-3422.
64. Simon D, Laloo B, Barillot M etal. 2010. A mutation in the 3'-UTR of the HDAC6 gene abolishing the post-transcriptional regulation mediated by hsa-miR-433 is linked to a new form of dominant X-linked chondrodysplasia. Hum Mol Genet 19:2015-2027.
65. Siomi H, Siomi MC. 2010. Posttranscriptional regulation of microRNA biogenesis in animals. Mol Cell 38:323-332.
66. Skog J, Wurdinger T, van Rijn S etal. 2008. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470-1476.
67. Slade I, Bacchelli C, Davies H etal. 2011. DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet 48:273-278.
68. Solda G, Robusto M, Primignani P etal. 2012. A novel mutation within the MIR96 gene causes non-syndromic inherited hearing loss in an Italian family by altering pre-miRNA processing. Hum Mol Genet 21:577-585.
69. Starczynowski DT, Kuchenbauer F, Argiropoulos B etal. 2010. Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med 16:49-58.
70. Stark KL, Xu B, Bagchi A etal. 2008. Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model. Nat Genet 40:751-760.
71. Tabares-Seisdedos R, Rubenstein JL. 2009. Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer. Mol Psychiatry 14:563-589.
72. Tassano E, Di Rocco M, Signa S, Gimelli G. 2013. De novo 13q31.1-q32.1 interstitial deletion encompassing the miR-17-92 cluster in a patient with Feingold syndrome-2. Am J Med Genet A 161A:894-896.
73. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. 2006. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20:2202-2207.
74. van Bokhoven H, Celli J, van Reeuwijk J etal. 2005. MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome. Nat Genet 37:465-467.
75. Wang L, Fidler C, Nadig N etal. 2008. Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays. Haematologica 93:994-1000.
76. Wang N, Tian ZQ, Li Y, Zhou RM, Wang GY. 2013. An A/G polymorphism rs3746444 in miR-499 is associated with increased cancer risk: a meta-analysis. Genet Mol Res 12:3955-3964.
77. Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. 2007. DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal. Nat Genet 39:380-385.
78. Williams Z, Ben-Dov IZ, Elias R etal. 2013. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci U S A 110:4255-4260.
79. Witkowski L, Mattina J, Schonberger S etal. 2013. DICER1 hotspot mutations in non-epithelial gonadal tumours. Br J Cancer 109:2744-2750.
80. Xiang Y, Fan S, Cao J, Huang S, Zhang LP. 2012. Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep 39:7019-7023.
81. Xu W, Ahmad A, Dagenais S, Iyer RK, Innis JW. 2012. Chromosome 4q deletion syndrome: narrowing the cardiovascular critical region to 4q32.2-q34.3. Am J Med Genet A 158A:635-640.
82. Yasmeen S, Melchior L, Bertelsen B, Skov L, Mol Debes N, Tumer Z. 2013. Sequence analysis of SLITRK1 for var321 in Danish patients with Tourette syndrome and review of the literature. Psychiatr Genet 23:130-133.
83. Zhao Y, Samal E, Srivastava D. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214-220.
84. Zhao Y, Ransom JF, Li A etal. 2007. Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2. Cell 129:303-317.